Watson Labs Teva Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?
WATSON LABS TEVA has fifty approved drugs.
There are two tentative approvals on WATSON LABS TEVA drugs.
Summary for Watson Labs Teva
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 42 |
| NDAs: | 50 |
Drugs and US Patents for Watson Labs Teva
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Teva | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 203959-004 | Apr 18, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Watson Labs Teva | SIMVASTATIN | simvastatin | TABLET;ORAL | 076685-003 | Dec 20, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Watson Labs Teva | FENOPROFEN CALCIUM | fenoprofen calcium | TABLET;ORAL | 072407-001 | Aug 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Watson Labs Teva | NORETHINDRONE AND ETHINYL ESTRADIOL | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 070687-001 | Jan 29, 1987 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for WATSON LABS TEVA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
